Primary prevention of cardiovascular disease in older adults in China

Table 2 Glycemic goals across different clinical conditions of older Chinese (men ≥ 45-year-old or women ≥ 55-year-old)

Clinical conditions	Glycemic goals
> 10 yr of life expectancy	HbA1c < 7%
Good medical support	Fasting plasma glucose < 7 mmol/L
High expected benefit from treatment	Postprandial blood glucose < 10.0 mmol/L
Low hypoglycaemia risk	Stabile blood glucose level
> 10 yr of life expectancy	HbA1c = 7%
New diagnosed and relatively young
No syndromes or complications
Low risk of treatment-related hypoglycaemia
Not using glycaemic-lowering medications or only use one type of non-insulin secretagogues
Good treatment adherence
> 10 yr life expectancy	HbA1c < 7.5%
Type I or type II diabetes
Mild syndromes or complications
Moderate risk of treatment-related hypoglycaemia
Receiving insulin secretagogues or insulin therapy
< 5 yr of life expectancy	HbA1c < 8%
Moderate syndromes or complications
Moderate risk of hypoglycaemia
Receiving insulin secretagogues or primarily multiple insulin injections
< 5 yr of life expectancy	HbA1c < 8.5%
Incapable to self-manage	Avoid acute diabetic complications or refractory infections caused by severe hyperglycaemia
	Blood glucose < 11.1 mmol/L